The portfolio accounted for $3 billion (€2.8B) in the 12 months to April 2023.
The company’s pet business sales accounted for $785.3 million (€731.7M) in the 3 months ending 30 April 2023.
This is up $67.2 million (€62.6M) from the same period in 2022. Excluding the noncomparable net sales in 2022 related to the divestiture of some of the firm’s pet food brands, net sales increased by $79.2 million (€73.6M).
The profit in the pet portfolio reached $145.5 million (€135.6M), a 21% increase.
Out of the other categories, such as coffee and human food, pet food represented the highest net sales for the company in the quarter.
According to CEO Mark Smucker, the Milk-Bone dog biscuit brand grew net sales by 20%. He told investors that dog food comparable net sales grew by 13% in the quarter. Cat food also noted growth within the Meow Mix brand, increasing 7% in net sales.
36% of total revenue in the year
Pet food sales accounted for $3 billion (€2.8B) in the last 12 months until 30 April 2023, making up 36% of the total revenue. In FY 2022, the pet portfolio hit $2.7 billion (€2.5B).
Cat food accumulated the majority of sales, totaling 34%, closely followed by snacks (33%) and dog food (31%).
Profit of the pet portfolio in the 12 months to 30 April 2023 also marked a positive incline to $494.9 million (€461.3M), up from $395.9 million (€368.9M) in the previous year.
J.M. Smucker said it is still struggling to meet demand and will invest in infrastructure to “improve efficiencies and increase throughout for the long-term.”
The firm’s net sales, including all businesses, reached $8.5 billion (€7.9B) in FY 2023.
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.